What is it about?

Critical assessment of preclinical and clinical data on the use of stem cells and stem cell-based products for the treatment of idiopathic pulmonary fibrosis

Featured Image

Why is it important?

The authors summarize the current status of the field and identify major challenges and opportunities for the possible future integration of stem cell-based treatments into the currently recommended clinical management strategy for idiopathic pulmonary fibrosis.

Read the Original

This page is a summary of: Stem Cell-Based Therapy in Idiopathic Pulmonary Fibrosis, Stem Cell Reviews and Reports, April 2015, Springer Science + Business Media,
DOI: 10.1007/s12015-015-9587-7.
You can read the full text:

Read

Contributors

The following have contributed to this page